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CNA+ medium did not identify intestinal carriage of ES-
BL-negative but mcr-1−positive enterobacteria in the index 
case-patient. On the basis of these results, rectal screening 
of 39 contacts was performed by using an ESBL-screening 
medium (BLSE agar [MacConkey agar and Drigalski agar]; 
bioMérieux). All of the tests showed negative results.
The origin of the mcr-1 strain remains unknown. Nos-
ocomial acquisition cannot be ruled out because colistin-
resistant strains harboring the mcr-1 gene might have been 
isolated in the hospital but not identified because this resis-
tance mechanism was initially reported in February 2016. 
Food might also be incriminated (1); one study identified a 
21% mcr-1 prevalence among ESBL-producing E. coli in 
calves in France (10).
Multiple antimicrobial drug therapy for this patient 
might have selected for this multidrug-resistant bacte-
ria. The presence of a plasmid containing the mcr-1 and 
ESBL or other resistance genes in the same strain might 
be involved in selection of colistin-resistant strains dur-
ing administration of any ineffective antimicrobial drug 
(3). Development of efficient tools for rapid detection of 
mcr-1−harboring strains should be a priority to prevent dis-
semination of these strains in hospital settings.
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We identified rmtE1, an uncommon 16S ribosomal methyl-
transferase gene, in an aminoglycoside- and cephalospo-
rin-resistant Escherichia coli sequence type 448 clinical 
strain co-harboring blaCMY-2. Long-read sequencing re-
vealed insertion of a 101,257-bp fragment carrying both 
resistance genes to the chromosome. Our findings under-
score E. coli sequence type 448 as a potential high-risk 
multidrug-resistant clone.
RmtE (RmtE1 and its variant RmtE2) is an uncommon plasmid-mediated 16S rRNA methyltransferase (16S 
RMTase) found in gram-negative bacteria; only 4 strains 
have been reported to produce RmtE, all Escherichia coli, 
including 1 from the University of Pittsburgh Medical 
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Center (Pittsburgh, PA, USA) (1–3). We report the genetic 
context of rmtE (rmtE1) in another E. coli clinical strain 
identified at this hospital.
E. coli YDC774 was identified in 2016 in the urine 
of a local elderly man with a history of bladder cancer 
for which he had undergone transurethral resection of the 
bladder and completed chemotherapy. He had E. coli uri-
nary tract infection treated with ciprofloxacin 3 months 
earlier; further details were unavailable. E. coli YDC774 
was resistant to cefotaxime, levofloxacin, ciprofloxacin, 
and trimethoprim/sulfamethoxazole and susceptible to 
ceftazidime, cefepime, piperacillin/tazobactam, imipen-
em, meropenem, minocycline, and colistin. The strain was 
highly resistant to amikacin (MIC >32 µg/mL), gentamy-
cin (MIC >16 µg/mL), and tobramycin (MIC >8 µg/mL). 
Because the positive culture was believed to represent as-
ymptomatic bacteriuria, the patient was not treated with 
antimicrobial drugs.
We aimed to elucidate the genetic context of rmtE in 
E. coli YDC774. Although rmtE has been identified ex-
clusively on plasmids, neither broth conjugation with E. 
coli J53 nor transformation of E. coli TOP10 with puri-
fied plasmids mobilized rmtE, leading us to speculate the 
gene might be located on the chromosome. We therefore 
sequenced the YDC774 genome with PacBio RS II se-
quencing instrument (Pacific Biosciences, Menlo Park, 
CA, USA) as described (4). Sequencing with a single 
SMRT cell yielded 64,878 reads averaging 10,991 bp. De 
novo assembly generated 8 contigs; the largest was ≈4.3 
Mbp, which had ≈122× coverage and was consistent with 
a large portion of the E. coli chromosome.
E. coli YDC774 belonged to sequence type (ST) 448 
by in silico multilocus sequence typing. E. coli ST448 
has been reported in recent years among extended-
spectrum β-lactamase– and New Delhi–type metallo-
β-lactamase–producing strains (5,6). The chromosomal 
contig contained rmtE (rmtE1 allele), blaCMY-2, aac(3)-
VIa, aadA, strA/B, floR, sul1, sul2, tet(A), and dfrA7 
as determined by ResFinder (https://cge.cbs.dtu.dk/ser-
vices/ResFinder/). We identified no resistance genes on 
the other contigs, including those representing a 96-kb 
IncY plasmid resembling p12579_1 (GenBank acces-
sion no. CP003110.1) in enteropathogenic E. coli strain 
RM12579 (99% identity over 83% coverage). Several 
other 16S RMTase genes, such as rmtB, rmtC, and rmtF, 
have been found on the chromosome of gram-negative 
bacteria (7,8).
The region surrounding rmtE1 was annotated with 
Rapid Annotations by using Subsystem Technology serv-
er (http://rast.nmpdr.org) and curated manually by using 
blastn and blastp (http://blast.ncbi.nlm.nih.gov/blast) 
to elucidate the context of its chromosomal integration. 
Using E. coli ATCC 25922 as the reference genome, we 
determined that a 101,257-bp sequence was inserted in 
an intergenic region between the 4′-phosphopantetheinyl 
transferase gene and the NAD(P)H nitroreductase gene on 
the E. coli chromosome.
This inserted sequence can be divided into 2 regions. 
The first comprises several inserted sequences, such as 
IS186, ISCR1, and 1 antimicrobial resistance gene, aadA. 
Downstream of this first region, the inserted fragment is 
similar to that in pYDC637, an IncA/C plasmid carrying 
rmtE1 also found at the University of Pittsburgh Medical 
Center in 2012 (online Technical Appendix Figure, https://
wwwnc.cdc.gov/EID/article/23/5/16-2000-Techapp1.pdf) 
(2). However, the second region comprises 3 small frag-
ments. The first contains aadA1-bx, 4 mobile elements, 
and several other genes and is in reverse orientation from 
that of pYDC637. The second small fragment harboring 
blaCMY-2 is identical to that found in the core region in 
pYDC637 (online Technical Appendix Figure) and also 
is in reverse orientation from the corresponding region 
of pYDC637. The third small fragment harboring rmtE is 
located in the acquired region of pYDC637. This finding 
suggests that, on mobilization into the chromosome, gene 
rearrangements occurred among these fragments. The 
region between 2 hypothetical proteins appears to have 
been deleted at or after integration, which includes genes 
involved in plasmid replication and conjugative transfer 
(online Technical Appendix Figure).
rmtE1 is bound by an ISCR20-like element and an 
IS1294-like insertion sequence. This immediate unit is 
identical to that found in pYDC637. ISCR20 and IS1294 
belong to IS91 family, which is considered related to some 
antimicrobial drug resistance genes, including 16S RMTase 
genes, which appears to have been the case in the mobiliza-
tion of rmtE1 as well. We could not identify direct repeats 
upstream and downstream of the unit that would define 
the exact boundary of this unit. In comparing the genetic 
context of rmtE1 and rmtE2, ISCR20-like transposase is 
located upstream of rmtE1 and rmtE2 (GenBank accession 
nos. KT428293 and NZ_LRIX01000127). However, the 
transposase genes located downstream of the 2 16S RM-
Tase genes are distinct. The genetic environment of rmtE2 
is identical between the 2 plasmids from China (GenBank 
accession no. KT428293) and Canada (GenBank accession 
no. NZ_LRIX01000127).
In summary, we identified chromosomal integration 
of rmtE1, an unusual 16S RMTase, and blaCMY-2, a com-
monly observed acquired AmpC β-lactamase, in an E. coli 
ST448 clinical strain, an event that generated stable co-
resistance to aminoglycosides and oxyiminocephalospo-
rins. We found no evidence of further spread of this strain 
in the hospital. Nonetheless, the findings underscore E. 
coli ST448 as a potential high-risk multidrug-resistant E. 
coli clone.
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We analyzed carbapenem-resistant Enterobacteriaceae 
(CRE) trends among patients from the US Veterans Health 
Administration (VHA). After the emergence of CRE in the 
eastern United States, resistance rates remained stable in 
Klebsiella pneumoniae but increased in Enterobacter cloa-
cae complex, suggesting a “second epidemic.” VHA offers a 
vantage point for monitoring nationwide CRE trends.
Carbapenem-resistant Enterobacteriaceae (CRE) have become a global public health threat. The epidemic of 
CRE began in the early 2000s with an outbreak of carbape-
nem-resistant Klebsiella pneumoniae harboring K. pneu-
moniae carbapenemase (KPC) in the eastern United States. 
Since then, KPC-producing K. pneumoniae have emerged 
in various communities across the country (1). Carbapenem 
resistance also occurs in other Enterobacteriaceae species 
and can be mediated by other enzymes, such as OXA-48 
and metallo-β-lactamases, especially New Delhi metallo-
β-lactamase and Verona integron–encoded metallo-β-
lactamase (1). Carbapenem-resistant Escherichia coli oc-
curs infrequently, but recent outbreaks of KPC-producing 
Enterobacter cloacae raise concerns about the emergence 
of carbapenem resistance in the E. cloacae complex (1–4).
The Veterans Health Administration (VHA) is the larg-
est integrated healthcare system in the United States. Clini-
cal and microbiologic data for the entire VHA network are 
accessible through its informatics platforms (5). We used 
this infrastructure to observe national trends of carbapenem 
resistance and nonsusceptibility in K. pneumoniae and E. 
cloacae complex during the past decade.
We identified 224,651 K. pneumoniae and 71,462 
E. cloacae complex (E. cloacae, E. asburiae, E. kobei, 
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